Crunching the numbers for NRXS... Refresh in a moment for the full analysis.
Neuraxis, INC (NRXS)
Healthcare
weak
$6.84
Updated: 2026-04-13
40
TradeApes Score
reduce
Financial Strength
35
Weak
Operating Trend
63
Healthy
Valuation
40
Weak
Capital Allocation
10
Stressed
Risk
35
Weak
Key Findings
+
Strong revenue growth — sales up more than 20% year over year
−
Weak interest coverage — earnings barely cover debt service
See the full analysis
Quarterly financials, DCF valuation model, Watchlist, and Stock Screener.
Add to Watchlist
Scores and valuations are model outputs, not investment advice. TradeApes does not provide financial, tax, or investment advice.